Tilray Brands Inc. (NASDAQ: TLRY) stocks were up 10.74% to $6.26 in premarket trading on Wednesday. The brand has made no announcement to support the price increase.
Tilray Brands (TLRY) closed the previous trading session at $5.68, up 6.77%. The company’s shares were priced between $5.29 and $5.71. It traded 15.54 million shares, which was less than its 100-day daily average of 21.96 million shares. TLRY’s shares have increased by 13.60 percent in the last five days but have decreased by 11.11 percent in the previous month.
Furthermore, the all-time high Tilray Brands stock closing price on September 19, 2018, was 214.06. The 52-week high stock price for TLRY is 24.13, which is 324.8% higher than the current share price, and the 52-week low stock price is 4.78, which is 15.8% lower. Its average stock price over the last 52 weeks has been $12.24.
The Zacks Rank system, which ranks stocks from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating a +25 percent average annual return since 1988. Within the last month, the Zacks Consensus EPS estimate has remained unchanged. Tilray Brands, Inc. currently has a Zacks Rank of #3 (Hold).
The current consensus among 21 investment analysts polled is to hold Tilray Brands Inc. stock.
Tilray Brands announced last week that its medical cannabis division, Tilray Medical, has expanded its medical cannabis offering and shipped the main EU GMP medical cannabis oil items to Malta.
Tilray is a Canadian company that grows and sells medical and recreational marijuana. In 2021, legacy Aphria reverse-merged with legacy Tilray and renamed itself Tilray. The majority of its sales are in Canada and the international medical cannabis export market. CBD products from Manitoba Harvest and beer from SweetWater are available in the United States.